Browsing: Novo Nordisk
Investor optimism about the pill version of weight-loss injectables being developed by Sam Chun Dang Pharm (SCD) in South Korea…
Novo Nordisk’s stock is experiencing a steep drop following major clinical setbacks and intensifying competitive pressure in the weight-loss-drug market.U.S.-listed…
In this week’s edition of InnovationRx, we look at the battle for Metsera, the departure of FDA’s top drug regulator,…
Amid wider economic uncertainty, some analysts have said that businesses are at a “no-hire, no fire” standstill. That’s caused many to…
Novo Nordisk A/S Chairman Helge Lund is stepping down after a boardroom dispute over the pace of change and will…
Novo Nordisk A/S reclaimed its position as Europe’s most valuable public company, overtaking software developer SAP SE. Shares in the…
GLP-1 users taking drugs like Ozempic and Wegovy are spending less on eating at restaurants and on take-out dinners, according…
When Novo Nordisk A/S Chief Executive Officer Lars Fruergaard Jorgensen dialed into a Teams video call with Chairman Helge Lund,…
Novo Nordisk A/S ousted Chief Executive Officer Lars Fruergaard Jorgensen as the drugmaker struggles with growing competition for its obesity…
© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use…